TOP TIERMARKET NEWSWIRE
News & sentiment

LIGAND PHARMACEUTICA (LGND) — News & AI sentiment

LIGAND PHARMACEUTICA (LGND) news roundup. 1 story in the last 24 hours, 2 in the past week, 6 over 30 days. Average 24-hour sentiment is 52/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 5 sales totalling $14.5M — net selling of $14.5M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 52/100
7d stories
2
avg sentiment 52/100
30d stories
6
avg sentiment 52/100
Insider net (90d)
$14.5M
0 buys · 5 sells
Congress (90d)
0
0 buys · 0 sells

LGND news in the last 24 hours, 7 days, 30 days and 90 days

How much LGND coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowLGND storiesAvg AI sentimentRead
Last 24 hours152/100LGND headlines →
Last 7 days252/100LGND headlines →
Last 30 days652/100LGND headlines →
Last 90 days4257.5/100LGND headlines →

Latest stories on LGND

17h ago
Ligand to Host Investor Day on December 8, 2026
GlobeNewswire52 · neutralgeneral
6d ago
Oct 15
Oct 15
StoneX updates its best ideas list
Seeking Alpha55 · neutralgeneral
Oct 1
Sep 28
Sep 25
Sep 25
Barclays initiates Ligand Pharma stock with overweight rating
Investing.com Analyst Ratings63 · neutralanalyst
Sep 25
Sep 24
Sep 24
Oppenheimer reiterates Ligand Pharma stock rating on AvenCell deal
Investing.com Analyst Ratings56 · neutralanalyst
Sep 24
Sep 24
Sep 24
Sep 24
Sep 24
Sep 23
Sep 22
Sep 22
Sep 22
Sep 22
Sep 22
Sep 19
Sep 18
Sep 12
Open LGND in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →